Skip to main content

GeneDx Holdings Corp.

WGS
Exchange
Nasdaq
Industry
Services-Health Services
SEC CIK
0001818331

In the last 90 days, GeneDx Holdings Corp. insiders filed 0 open-market purchases and 5 sales; 223 institutions reported holding it in 13F filings for Q2 2026, worth $2.17B in total; ARK Invest is the only superinvestor holding it.

Q4 2022 vs. Q3 2022

How the institutions holding GeneDx Holdings Corp. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of WGS: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders9888−10
Shares158.3M141.5M−16.8M (−10.6%)
Value$138.1M$37.3M−$100.9M (−73.0%)

New holders (13)

Institutions that held GeneDx Holdings Corp. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to WGS in Q4 2022
InstitutionSharesValue% of portfolio
HRT Financial LP570,852$150.0K0.00%
HighTower Advisors, LLC517,634$134.0K0.00%
Jane Street Group, LLC236,750$62.5K0.00%
Two Sigma Investments, LP136,593$36.0K0.00%
UBS Group AG91,659$23.8K0.00%
Acadian Asset Management LLC82,055$21.0K0.00%
Two Sigma Advisers, LP69,700$18.4K0.00%
Bayesian Capital Management, LP35,747$9.43K0.00%
Connor, Clark & Lunn Investment Management Ltd.18,852$4.97K0.00%
Cornerstone Planning Group LLC520$1920.00%
Sofos Investments, Inc.0$60.00%
Money Concepts Capital Corp2$10.00%
Nisa Investment Advisors, LLC1,100$00.00%

Sold out (23)

Institutions that held GeneDx Holdings Corp. at the end of Q3 2022 and filed for Q4 2022 without it.